Abstract:Background Recent studies have discovered that nuclear translocation of nerve growth factor (NGF) and its receptor fragments function differently from the traditional model. This study aimed to uncover the nuclear expression of NGF in astrocytoma and its biological significance.Methods Ninety-four paraffin-embedded astrocytoma specimens were subjected to immunohistochemical (IHC) and hemotoxylin & eosin (HE) staining. Preoperative cerebrospinal fluid (CSF) specimens and intraoperative snap-frozen astrocytoma tissues were assayed for NGF expression by ELISA and Western blotting. The outcome of patients who contributed samples was tracked. Each ten tissue samples from patients with traumatic brain injury who had received decompression surgery and CSF samples from patients undergoing spinal anesthesia but with no history of nervous system disease were taken as control.Results NGF-positive immunoreactive products were distributed in both the cytoplasm and nucleus of astrocytoma, but were only located in the cytoplasm of traumatic brain injury (TBI) tissue. NGF nuclear-positive rate (NPR) of grades III-IV astrocytomas (70.0%) was higher than that of grades I-II astrocytoma (28.6%, P <0.05). NGF-NP expression positively correlated with the NGF concentration in cerebrospinal fluid (CSF) (r=0.755, P <0.01). Kaplan-Meier survival analysis indicated that the median survival time was 25 months for NGF-NP astrocytoma grade I-II patients and 42 months in NGF nuclear negative (NGF-NN) astrocytoma grade I-II patients (P <0.05). In astrocytoma III-IV patients, the median survival was 7 months for NGF-NP patients and 24 months for NGF-NN patients (P <0.01). Two types of NGF with molecular weights of 13 and 36 kDa were present in astrocytoma, but only the 36 kDa NGF was found in the CSF. NGF expression elevated as the malignancy increased.Conclusions NGF-NP expression and NGF level in CSF were significant prognostic factors in astrocytoma patients. Because of the easy access of CSF, it may be developed as an index for early diagnosis and surveillance of astrocytoma. Chin Med J 2011;124(14):2222-2227

Significance of NF-κB Expression in Human Cerebral Tumors

NF-κB Expression in the Astrocytic Tumors and Its Relation to Tumor Proliferation

NF-κB P65,vegf Expression and Their Relation to the Clinical Pathology in the Gliomas

Correlation between activation NF-κB and apoptosis in astrocytic tumor

Expression of NF-κB p65 Protein in Colorectal Adenocarcinoma and Large Intestine Adenoma

[Expression of NF-kappa B in Human Bladder Cancer and Its Clinical Significance].

[Expressions of NF-kappaB P65 in Laryngeal Carcinoma and Normal Mucous Membrane and Its Clinical Significance].

Expressions of NF-κB and Upa in Human Cerebral Glioma

Clinical significance of immunohistochemically detecting forkhead box P3 expression in human astrocytic tumors

Expression and Clinical Significance of Nuclear Factor kappa B p65 and Tumor Necrosis Factor α in Cervical Carcinogenesis

Clinical signif icance of nuclear factor κB expression in primarygastrointestinal diffuse large B-cell lymphoma

Id-1 and the P65 Subunit of NF-κB Promote Migration of Nasopharyngeal Carcinoma Cells and Are Correlated with Poor Prognosis

Expression and significance of IKK,IκB and NF-κB in NSCLC

Expression and significance of Fas and Bcl-2 proteins in human astrocytoma

Quantitative analysis of NF1 and OMGP gene transcripts in sporadic gliomas, sporadic meningiomas and neurofibromatosis type 1-associated plexiform neurofibromas

Nerve Growth Factor Expression in Astrocytoma and Cerebrospinal Fluid: a New Biomarker for Prognosis of Astrocytoma.

Expression and significance of NF-κB in gastric carcinoma

Prognostic Value of Expression of Nuclear Factor Kappa-B/p65 in Non-Gcb DLBCL Patients

Nuclear Factor-Kappa B1 Inhibits Early Apoptosis of Glioma Cells by Promoting the Expression of Bcl-2.

Expression and clinical significance of NGF and TrkA in astrocytoma tissue

The Expression and Significance of Nuclear Transcription Factor-Κb P65 and PTEN in Colorectal Cancer